載入...

Class II-associated invariant chain peptide as predictive immune marker in minimal residual disease in acute myeloid leukemia

The majority of patients with acute myeloid leukemia (AML) reach complete remission after high-dose chemotherapy. Still, half of these patients experience a relapse due to presence of minimal residual disease (MRD). Here we discuss the poor prognostic role of class II-associated invariant chain pept...

全面介紹

Na minha lista:
書目詳細資料
發表在:Oncoimmunology
Main Authors: van Luijn, Marvin M, van den Ancker, Willemijn, van Ham, S Marieke, van de Loosdrecht, Arjan A
格式: Artigo
語言:Inglês
出版: Taylor & Francis 2014
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4353169/
https://ncbi.nlm.nih.gov/pubmed/25964856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.941737
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!